Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS),...
United Immunity, Co., Ltd., a biotechnology company developing its proprietary Myeloid Targeting Platform™ for therapeutic in vivo engineerin...
EpiCypher® and New England Biolabs® (NEB®) announced an expanded strategic partnership to co-develop next-generation tools for epigenom...
The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioanal...
ProtaGene announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to...
ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD ...
SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) announced that they have entered into an ...
Virtual Science AI announces the launch of Medical Competitor AI, an AI solution that analyses competitor medical activity and scientific narratives. The...
Ceremonial groundbreaking kicks off the first construction phase Pharmaceutical service provider advances its expansion with a 50,000 sqm facility S...
Proton therapy CBCT imaging solution across Proteus® Portfolio providing clarity and confidence in IGPT IBA (Ion Beam Applications S.A., EURON...
Roche has received CE Mark approval for Elecsys® pTau217, a blood-based diagnostic test designed to detect phosphorylated Tau (pTau) 217 protein, a k...
New collaboration strengthens connections across the global biotech ecosystem Basel Area Business & Innovation, the strategic growth partner helping...
arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced the launch of its immunoMUSE® kits, based on its ...
Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income ...
© 2026 Biopharma Boardroom. All Rights Reserved.
